Frontlight ResearchEarly access
Trial site
Jan Yperman Ziekenhuis
- 9running trials
- 5closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Chronic kidney disease6 trials
- Coronary artery disease3 trials
- Stroke3 trials
- Type 2 diabetes3 trials
- Atrial fibrillation2 trials
- High blood pressure2 trials
- Obesity2 trials
- Chronic lymphocytic leukaemia1 trial
- Endometrial cancer1 trial
- Familial hypercholesterolaemia1 trial
- Heart failure1 trial
- IgA nephropathy1 trial
- and 2 more
- Phase
- Phase 39 trials
- Phase 22 trials
- Phase 42 trials
- Status
- Recruiting6 trials
- Completed5 trials
- Active, not recruiting3 trials
- Lead sponsor
- Eli Lilly and Company3 trials
- AstraZeneca2 trials
- Bayer2 trials
- Acerta Pharma BV1 trial
- Biogen1 trial
- and 5 more
Running trials
Recruiting
Flecainide Safety in Patients With Coronary Artery Disease and Atrial Fibrillation
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Atrial fibrillation2 recruiting
- Chronic kidney disease2 recruiting
- Coronary artery disease2 recruiting
- Stroke2 recruiting
- High blood pressure1 recruiting
- IgA nephropathy1 recruiting
- Obesity1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
Completed
Completed
Active, not recruiting
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026